Patents by Inventor Ana Brandusa Pavel

Ana Brandusa Pavel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230255998
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: July 19, 2022
    Publication date: August 17, 2023
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Publication number: 20230220479
    Abstract: The present invention features biomarkers for diagnosis and treatment of dermatological diseases, e.g., psoriasis and atopic dermatitis. The disclosure provides a minimally invasive method of determining levels of biomarkers (e.g., NOS2/iNOS) in surface skin samples.
    Type: Application
    Filed: January 17, 2023
    Publication date: July 13, 2023
    Inventors: Ana Brandusa Pavel, Emma Guttman-Yassky
  • Patent number: 11426423
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: August 30, 2022
    Assignee: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Publication number: 20220195056
    Abstract: The present disclosure relates to methods for diagnosing and staging keloids, and to methods of treating keloids using therapeutic compositions that inhibit the Th2 cytokine signaling pathway.
    Type: Application
    Filed: August 6, 2020
    Publication date: June 23, 2022
    Applicant: Icahn School of Medicine at Mount Sinai
    Inventors: Emma Guttman-Yassky, Ana Brandusa PAVEL
  • Publication number: 20210369650
    Abstract: The invention relates to a halogenated salicylanilide selected from niclosamide and oxyclozanide, or a pharmaceutically acceptable salt or hydrate thereof, for use in topical anti-inflammatory treatment of one or more clinical signs or symptoms of an inflammatory skin condition in a subject, wherein the one or more clinical signs or symptoms are associated with an abnormal inflammatory response, and the topical anti-inflammatory treatment modulates expression in lesional skin of one or more immune effectors selected from proinflammatory mediators and skin barrier molecules.
    Type: Application
    Filed: November 2, 2018
    Publication date: December 2, 2021
    Inventors: Emma GUTTMAN-YASSKY, Morten Otto Alexander SOMMER, Rasmus TOFT-KEHLER, Anne WEISS, Ana Brandusa PAVEL
  • Publication number: 20200222446
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: March 24, 2020
    Publication date: July 16, 2020
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Patent number: 10632140
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: April 28, 2020
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Publication number: 20190247418
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 15, 2019
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Patent number: 10314855
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: June 11, 2019
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Spira
  • Publication number: 20180207196
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: January 23, 2018
    Publication date: July 26, 2018
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Spira